These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 22957021

  • 1. Corticotropin-releasing hormone receptor 1 gene variants in irritable bowel syndrome.
    Sato N, Suzuki N, Sasaki A, Aizawa E, Obayashi T, Kanazawa M, Mizuno T, Kano M, Aoki M, Fukudo S.
    PLoS One; 2012; 7(9):e42450. PubMed ID: 22957021
    [Abstract] [Full Text] [Related]

  • 2. Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome.
    Komuro H, Sato N, Sasaki A, Suzuki N, Kano M, Tanaka Y, Yamaguchi-Kabata Y, Kanazawa M, Warita H, Aoki M, Fukudo S.
    PLoS One; 2016; 11(1):e0147817. PubMed ID: 26808377
    [Abstract] [Full Text] [Related]

  • 3. Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response.
    Orand A, Naliboff B, Gadd M, Shih W, Ju T, Presson AP, Mayer EA, Chang L.
    Psychoneuroendocrinology; 2016 Nov; 73():133-141. PubMed ID: 27497153
    [Abstract] [Full Text] [Related]

  • 4. Associations between Single-Nucleotide Polymorphisms in Corticotropin-Releasing Hormone-Related Genes and Irritable Bowel Syndrome.
    Sasaki A, Sato N, Suzuki N, Kano M, Tanaka Y, Kanazawa M, Aoki M, Fukudo S.
    PLoS One; 2016 Nov; 11(2):e0149322. PubMed ID: 26882083
    [Abstract] [Full Text] [Related]

  • 5. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S.
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [Abstract] [Full Text] [Related]

  • 6. Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome.
    Tanaka Y, Kanazawa M, Kano M, Morishita J, Hamaguchi T, Van Oudenhove L, Ly HG, Dupont P, Tack J, Yamaguchi T, Yanai K, Tashiro M, Fukudo S.
    PLoS One; 2016 Jan; 11(7):e0157347. PubMed ID: 27448273
    [Abstract] [Full Text] [Related]

  • 7. Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.
    Labus JS, Hubbard CS, Bueller J, Ebrat B, Tillisch K, Chen M, Stains J, Dukes GE, Kelleher DL, Naliboff BD, Fanselow M, Mayer EA.
    Gastroenterology; 2013 Dec; 145(6):1253-61.e1-3. PubMed ID: 23954313
    [Abstract] [Full Text] [Related]

  • 8. Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome.
    Wouters MM, Lambrechts D, Knapp M, Cleynen I, Whorwell P, Agréus L, Dlugosz A, Schmidt PT, Halfvarson J, Simrén M, Ohlsson B, Karling P, Van Wanrooy S, Mondelaers S, Vermeire S, Lindberg G, Spiller R, Dukes G, D'Amato M, Boeckxstaens G.
    Gut; 2014 Jul; 63(7):1103-11. PubMed ID: 24041540
    [Abstract] [Full Text] [Related]

  • 9. Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients.
    Kussainova A, Kassym L, Bekenova N, Akhmetova A, Glushkova N, Kussainov A, Urazalina Z, Yurkovskaya O, Smail Y, Pak L, Semenova Y.
    PLoS One; 2022 Jul; 17(7):e0271719. PubMed ID: 35905107
    [Abstract] [Full Text] [Related]

  • 10. Association of the -1438 G/A and 102 T/C polymorphism of the 5-Ht2A receptor gene with irritable bowel syndrome 5-Ht2A gene polymorphism in irritable bowel syndrome.
    Pata C, Erdal E, Yazc K, Camdeviren H, Ozkaya M, Ulu O.
    J Clin Gastroenterol; 2004 Aug; 38(7):561-6. PubMed ID: 15232358
    [Abstract] [Full Text] [Related]

  • 11. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M, Hongo M, Fukudo S.
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [Abstract] [Full Text] [Related]

  • 12. The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome.
    Kilpatrick LA, Labus JS, Coveleskie K, Hammer C, Rappold G, Tillisch K, Bueller JA, Suyenobu B, Jarcho JM, McRoberts JA, Niesler B, Mayer EA.
    Gastroenterology; 2011 Jun; 140(7):1943-51. PubMed ID: 21420406
    [Abstract] [Full Text] [Related]

  • 13. Aneurysmal subarachnoid haemorrhage: effect of CRHR1 genotype on fatigue and depression.
    Vetkas A, Prans E, Kõks S, Rätsep T, Asser T.
    BMC Neurol; 2020 Apr 18; 20(1):142. PubMed ID: 32305063
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome.
    Romero-Valdovinos M, Gudiño-Ramírez A, Reyes-Gordillo J, Martínez-Flores WA, Ramírez-Miranda ME, Maravilla P, Olivo-Díaz A.
    Mol Biol Rep; 2012 Sep 18; 39(9):8837-43. PubMed ID: 22740130
    [Abstract] [Full Text] [Related]

  • 15. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
    Kano M, Muratsubaki T, Van Oudenhove L, Morishita J, Yoshizawa M, Kohno K, Yagihashi M, Tanaka Y, Mugikura S, Dupont P, Ly HG, Takase K, Kanazawa M, Fukudo S.
    Sci Rep; 2017 Sep 29; 7(1):12425. PubMed ID: 28963545
    [Abstract] [Full Text] [Related]

  • 16. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.
    Swan C, Duroudier NP, Campbell E, Zaitoun A, Hastings M, Dukes GE, Cox J, Kelly FM, Wilde J, Lennon MG, Neal KR, Whorwell PJ, Hall IP, Spiller RC.
    Gut; 2013 Jul 29; 62(7):985-94. PubMed ID: 22684480
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 - A Randomized Clinical Trial.
    Khalighi Sikaroudi M, Mokhtare M, Janani L, Faghihi Kashani AH, Masoodi M, Agah S, Abbaspour N, Dehnad A, Shidfar F.
    Complement Med Res; 2020 Jul 29; 27(5):302-309. PubMed ID: 32203968
    [Abstract] [Full Text] [Related]

  • 18. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.
    van der Veek PP, van den Berg M, de Kroon YE, Verspaget HW, Masclee AA.
    Am J Gastroenterol; 2005 Nov 29; 100(11):2510-6. PubMed ID: 16279907
    [Abstract] [Full Text] [Related]

  • 19. A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.
    Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ.
    Gastroenterology; 2011 Jun 29; 140(7):1934-42. PubMed ID: 21396369
    [Abstract] [Full Text] [Related]

  • 20. Ghrelin Gene Polymorphisms in Irritable Bowel Syndrome.
    Kalli T, Koutouratsas T, Karamanolis G, Gazouli M.
    Digestion; 2021 Jun 29; 102(3):313-318. PubMed ID: 32294653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.